[email protected]

国际中医药研究

International Research in Chinese Medicine

您当前位置:首页 > 编委信息

贾永亮

职称:副教授

单位:郑州大学河南省医药科学研究院

社会任职:

个人简介

贾永亮,博士,副教授,中国党员,硕士生导师。主要研究方向:(1)循证医学方面证据质量评价和疗效综合比较;(2)生物信息学和临床试验的数据挖掘和分析;(3)证据理论和论证理论在医学决策中的应用;(4)生物信息学多源证据的合并分析疾病的潜在病因;(5)大量数据和统计分析自动化和智能化。

教育经历

  • 澳门大学 哲学博士·生物医药
  • 澳门大学 理学硕士·医药管理
  • 兰州大学 医学学士·药学
  • 兰州大学 理学 (双)学士·电子信息科学与技术

学术贡献

  • 1、(部分期刊论文 )
  • 2、1. Xiuli Mo, Zhengyu Duan, Weihong Zhang, Yongliang Jia*. Clinical evidence of exercise intervention in improving adults with type 2 diabetes mellitus and frailty: A narrative literature review. Frontiers in Physiology 2026; 17:1791522. (通讯作者, JCR1 区, 中科院 2 区)
  • 3、2. Yongliang Jia, Jianxiang Shi, Hong’en Xu, Youmei Peng, Jiancheng Guo*, Shuiling Jin*. Exploration of a Postgraduate Scientific Paper Guidance Model Based on Three-Stage Empowerment and Dual-Tutor Collaboration. Lecture Notes in Education 2025; 3: 14-19. (第一作者,研究生教改论文)
  • 4、3. Jianxiang Shi, Yongliang Jia, Hong'en Xu, Xiaofei Wang, Shuiling Jin, Jiancheng Guo, Wenjun Shang. Construction of a Blended Theoretical Teaching Model for Pharmacogenomics Under the Background of Precision Medicine. Lecture Notes in Education 2025, 3(11), 56–61. (第二作者,研究生教改论文)
  • 5、4. Zhengyu Duan, Xiuli Mo, Lanxu Jia, Haoyuan Li, Xiaonan Liang, Shuiling Jin, Yongliang Jia*. Efficacy and safety of AiDi injection in treating primary liver cancer: a systematic review on 70 randomized controlled trials. Scientific Reports 2025;16(1):1414. (通讯作者, JCR1 区,中科院 3 区)
  • 6、5. Weidong Wu, Bin Liu, Qing Zhang, Xiaojuan Zhang, Pengya Feng *, Yongliang Jia*, Xia Xue *. Heterogeneity and efficacy of immunotherapy in multiple cancer: insights from a meta-analysis. Biological Procedures Online 2025. 27(1):17. (共同通讯作者, JCR1 区,中科院 2 区)
  • 7、6. Yongliang Jia†, Xiaonan Liang, Hongmei Zhu, Lanxu Jia, Weihong Zhang. Evidence map construction of acupuncture for type 2 diabetes mellitus and depression. Proceedings of the 2025 International Conference on Health Big Data. New York, NY, USA: Association for Computing Machinery; 2025; 216-220. (第一作者,EI)
  • 8、7. Yongliang Jia†, Siu-wai Leung*. The efficacy of Chinese herbal drugs for adults with angina pectoris: Bayesian network meta-analysis of 331 RCTs involving 36,467 individuals. Journal of Ethnopharmacology 2024. 326: 117925. (第一作者, JCR1 区, 中科院 1 区)
  • 9、8. Jiangpeng Pan†, Yongliang Jia†*, Jianxiang Shi, Ruinan Yao, Jiancheng Guo*. The efficacy and safety of compound kushen injection for adults with esophageal cancer: A meta-analysis of randomized controlled trials. Journal of Ethnopharmacology 2024. 322: 117604. (共同第一/通讯作者, JCR1 区,中科院 1 区)
  • 10、9. Yongliang Jia†, Xiaonan Liang, Hui Zhou, Hongmei Zhu, Weihong Zhang. Potential mechanism of ginseng against frailty on network pharmacology and Bioinformatics analyses. Proceedings of the 2024 3rd International Conference on Public Health and Data Science. New York, NY, USA: Association for Computing Machinery; 2025; 175-182. (第一作者, EI)
  • 11、10. Hongmei Zhu, Yongliang Jia, Siu-wai Leung*. Citations of microRNA biomarker articles that were retracted: Asystematic review. JAMA Network Open 2024; 7(3): e243173. (第二作者, JCR1 区,中科院 1 区)
  • 12、11. Rui Zhang, Chang Su, Yongliang Jia, Menglu Xing, Shuiling Jin, Hong Zong. Molecular mechanisms of HER2-targeted therapy and strategies to overcome the drug resistance in colorectal cancer. Biomedicine & Pharmacotherapy 2024. 179: 117363. (第二作者, JCR1 区,中科院 1 区)
  • 13、12. Haodong Shang, Xinru Shen, Xiaoxiao Yu, Jing Zhang, Yongliang Jia*, and Feng Gao*. B-cell targeted therapies in autoimmune encephalitis: mechanisms, clinical applications, and therapeutic potential. Frontiers in Immunology 2024; 15:1368275. (共同通讯作者, JCR1 区,中科院 2 区)
  • 14、13. Hui Zhou, Hongmei Zhu, Yongliang Jia*. Critical quality appraisal of randomized controlled trials with traditional Chinese medicines for the coronavirus disease 2019. Phytomedicine 2023. 120:155038. (通讯作者,JCR1 区,中科院 1 区)
  • 15、14. Yongliang Jia†*, Guoying Gao†, Siu-wai Leung. How efficacious are traditional Chinese medicine injections in treating angina pectoris? A network meta-analysis of randomized controlled trials. Journal of Ethnopharmacology 2023; 303:115996. (通讯作者, JCR1 区,中科院 1 区)
  • 16、15. Tong Wu, Tieliang Yue, Pengfei Yang, Yongliang Jia*. Notable efficacy of Shugan Jieyu capsule in treating adult with post-stroke depression: A PRISMA-compliant meta-analysis of randomized controlled trials. Journal of Ethnopharmacology 2022; 294;115367. (共同通讯作者, JCR1 区,中科院 1 区)

工作经历

  • 2021.02 – 迄今 郑州大学·河南省医药科学研究院 副教授,硕士生导师